174 related articles for article (PubMed ID: 28236145)
1. Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer.
Sundberg K; Wengström Y; Blomberg K; Hälleberg-Nyman M; Frank C; Langius-Eklöf A
Support Care Cancer; 2017 Jul; 25(7):2195-2204. PubMed ID: 28236145
[TBL] [Abstract][Full Text] [Related]
2. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
[TBL] [Abstract][Full Text] [Related]
3. Effects of an interactive mHealth innovation for early detection of patient-reported symptom distress with focus on participatory care: protocol for a study based on prospective, randomised, controlled trials in patients with prostate and breast cancer.
Langius-Eklöf A; Crafoord MT; Christiansen M; Fjell M; Sundberg K
BMC Cancer; 2017 Jul; 17(1):466. PubMed ID: 28676102
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
[TBL] [Abstract][Full Text] [Related]
5. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
[TBL] [Abstract][Full Text] [Related]
7. Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy.
Pettersson A; Johansson B; Persson C; Berglund A; Turesson I
Radiother Oncol; 2012 Jun; 103(3):333-40. PubMed ID: 22633817
[TBL] [Abstract][Full Text] [Related]
8. Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer - A randomized controlled trial.
Fjell M; Langius-Eklöf A; Nilsson M; Wengström Y; Sundberg K
Breast; 2020 Jun; 51():85-93. PubMed ID: 32247251
[TBL] [Abstract][Full Text] [Related]
9. Patients' Perspective on Participation in Care With or Without the Support of a Smartphone App During Radiotherapy for Prostate Cancer: Qualitative Study.
Hälleberg Nyman M; Frank C; Langius-Eklöf A; Blomberg K; Sundberg K; Wengström Y
JMIR Mhealth Uhealth; 2017 Jul; 5(7):e107. PubMed ID: 28747294
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
11. Decreased symptom burden following surgery due to support from an interactive app for symptom management for patients with pancreatic and periampullary cancer.
Gustavell T; Sundberg K; Segersvärd R; Wengström Y; Langius-Eklöf A
Acta Oncol; 2019 Sep; 58(9):1307-1314. PubMed ID: 31284797
[No Abstract] [Full Text] [Related]
12. Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study.
Crafoord MT; Fjell M; Sundberg K; Nilsson M; Langius-Eklöf A
J Med Internet Res; 2020 Aug; 22(8):e17058. PubMed ID: 32663140
[TBL] [Abstract][Full Text] [Related]
13. Symptoms and self-care strategies during and six months after radiotherapy for prostate cancer - Scoping the perspectives of patients, professionals and literature.
Blomberg K; Wengström Y; Sundberg K; Browall M; Isaksson AK; Nyman MH; Langius-Eklöf A
Eur J Oncol Nurs; 2016 Apr; 21():139-45. PubMed ID: 26482003
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
15. Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.
Schofield P; Gough K; Lotfi-Jam K; Bergin R; Ugalde A; Dudgeon P; Crellin W; Schubach K; Foroudi F; Tai KH; Duchesne G; Sanson-Fisher R; Aranda S
BMC Cancer; 2016 Aug; 16():637. PubMed ID: 27530156
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of an interactive ICT-platform for early assessment and management of patient-reported symptoms during radiotherapy for prostate cancer.
Sundberg K; Eklöf AL; Blomberg K; Isaksson AK; Wengström Y
Eur J Oncol Nurs; 2015 Oct; 19(5):523-8. PubMed ID: 25813529
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls.
Fransson P
Acta Oncol; 2008; 47(5):852-61. PubMed ID: 17899451
[TBL] [Abstract][Full Text] [Related]
18. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
19. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
[TBL] [Abstract][Full Text] [Related]
20. Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study.
Majumder K; Nilsson S; Johansson H; Ullén A; Lennernäs B; Bergenmar M; Brandberg Y
Eur J Cancer; 2016 Sep; 65():43-51. PubMed ID: 27459586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
